Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University Development (OUD), the £4bn joint venture between the University of Oxford and Legal & General Capital, has launched an international competition to find a team to design the masterplan for its world-leading £1billion, 190-hectare mixed-use Innovation District at Begbroke Science Park.

Begbroke Science Park from the air

The winning design team will set the bold ambition and design intent for a project that will transform the area around the University's Begbroke Science Park, to the north of Oxford. The project will also create a community of up to 2,000 quality homes, with new schools, a public park and nature reserve.

OUD and the University aspire to create a boundary-pushing scheme that achieves a step-change in sustainable design, delivery, and operation. The new district will seek to attract the very best minds, while driving economic growth, improving transport connections, delivering benefits for local people, and enhancing the surrounding natural landscape.

It will also provide an exemplary new setting for the University's world-leading science and innovation, which will help address key global challenges facing humanity - from food security and biodiversity to climate change and the urgent need to move to a zero-carbon economy.

The regeneration programme will be multi-phased. The first phase will provide new facilities for the University’s research and development, as well as providing space to incubate spin-out companies, while the second will involve the creation of the wider Innovation District.

Read the full story on the University of Oxford Estates Services website

Similar stories

New book expands the horizons of brain research

A pioneering book from Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch to be released on 1 February 2022 addresses the fundamental relationship between the body, brain and behaviour.

New research sheds light on how ultrasound could be used to treat psychiatric disorders

A new study in macaque monkeys has shed light on which parts of the brain support credit assignment processes (how the brain links outcomes with its decisions) and, for the first time, how low-intensity transcranial ultrasound stimulation (TUS) can modulate both brain activity and behaviours related to these decision-making and learning processes.

Dramatic fall in hospital admissions for child infections since start of Covid-19 pandemic

Since the onset of the Covid-19 pandemic, there have been dramatic reductions in hospital admissions for common and severe childhood infections in England, most likely due to social distancing measures, school and workplace closures, and travel restrictions, finds a study published by The BMJ today.

Rosalind Franklin Institute and Pharmacology announce strategic partnership in Next Generation Chemistry

The Rosalind Franklin Institute and the University of Oxford’s Department of Pharmacology have entered into a strategic partnership for Next Generation Chemistry.

Christoph Treiber awarded ERC Starting Grant to investigate the origins of behavioural diversity

Congratulations are in order for postdoctoral research scientist Dr Christoph Treiber who has been awarded a Starting Grant from the European Research Council. His funded project will investigate the genetic components that may contribute to diversity of brain function and behaviour.

New blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread

A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. The early success of this technology makes it the first blood-based test that not only detects cancer in this population but can simultaneously identify if a cancer has spread.